PDS Biotechnology
PDSB
PDSB
72 hedge funds and large institutions have $30.2M invested in PDS Biotechnology in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
58% less call options, than puts
Call options by funds: $635K | Put options by funds: $1.5M
Holders
72
Holding in Top 10
–
Calls
$635K
Puts
$1.5M
Top Buyers
| 1 | +$1.21M | |
| 2 | +$423K | |
| 3 | +$402K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$310K |
| 5 |
Jane Street
New York
|
+$283K |
Top Sellers
| 1 | -$1.99M | |
| 2 | -$1.99M | |
| 3 | -$542K | |
| 4 |
Morgan Stanley
New York
|
-$502K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$407K |